Rationale: Recent work in animal models and humans has demonstrated the presence of organ-specific progenitor cells required for the regenerative capacity of the adult heart. In response to tissue injury, progenitor cells differentiate into specialized cells, while their numbers are maintained through mechanisms of self-renewal. The molecular cues that dictate the self-renewal of adult progenitor cells in the heart, however, remain unclear.
A ccumulating evidence over the past decade in both humans and animal models has documented the presence of endogenous progenitor cells in adult myocardium. [1] [2] [3] [4] [5] [6] In response to local tissue injury, cardiac progenitor cells differentiate into specialized cells, while the pool of progenitor cells is maintained, in part, through self-renewal and enhanced proliferation. 7, 8 However, the molecular cues and signaling pathways that dictate the homeostasis of adult progenitor cells and in particular their self-renewal, in physiological and pathological states, remain unclear.
Wnt ligands constitute a family of 19 secreted glycoproteins that act as key regulators of cellular function during development, adulthood, and disease. 9, 10 Several reports have proposed time and context dependent roles for Wnt signaling in cardiogenesis and progenitor cell biology. 11 Studies in chick and Xenopus embryos have demonstrated that inhibition of Wnt signaling is required for cardiac differentiation, 12, 13 whereas Wnt signaling has also been found to promote cardiomyogenesis in Drosophila and embryonic carcinoma P19 cells. 14, 15 Moreover, early in gastrulation, Wnt ligands activate a cardiac differentiation program, whereas at later stages they act as potent inhibitors of the cardiomyogenic differentiation. 16, 17 Recent genetic studies have demonstrated that the canonical Wnt signaling cascade promotes the proliferation of neonatal and embryonic Isl-1 ϩ cardiac progenitors in vitro and in vivo. 18 -20 Little is known, however, regarding the role of Wnt signals in modulating adult progenitor cell populations.
Side population (SP) cells were initially identified based on their unique ability to efflux the DNA binding dye Hoechst 33342, 21 and were found to retain the long-term regenerative potential of bone marrow. Subsequently, SP cells were identified in various adult tissues/organs including adult myocardium. 22 Cardiac SP (CSP) cells are enriched in Sca1 but do not express c-kit or Isl-1. 6 More importantly, CSP cells are found to be capable of differentiation into functional cardiac myocytes in vitro or in vivo after myocardial infarction (MI). 6, [23] [24] [25] We demonstrate that in contrast to previous work in embryonic or early postnatal stem cells, Wnt signaling negatively regulates the proliferation of adult CSP progenitor cells, both in vitro and in vivo, through suppression of cell cycle progression. Moreover, Wnt activation exerts its antiproliferative effects through a previously unappreciated activation of IGFBP3, which is found to require intact IGF binding site for its action. Importantly, activation of Wnt signaling was found to limit CSP cell renewal after MI, impair endogenous regenerative capacity, and worsen post-MI structural and functional remodeling. Overall, our study represents the first investigation of the role of canonical Wnt pathway in the homeostasis of adult cardiac progenitor cells in both physiological and pathological states and highlights the importance of cardiac progenitor cells in maintaining tissue function after injury.
Methods
An expanded Methods section describing all procedures and protocols is available in the Online Data Supplement at http://circres.ahajournals.org.
Animals
C57BL/6J male and female mice (8 -12 weeks old) were purchased from Jackson Laboratory (Jackson East, MP 15). All animal procedures and handling were performed under the guidelines of Harvard Medical School, the Longwood Medical Area Institutional Animal Care and Use Committee (IACUC), and the National Society for Medical Research. MI was generated in C57BL/6J female mice as previously described. 26 MI size was estimated using histological imaging of three transverse myocardial sections (base, midpapillary, and apex) after staining with Masson trichrome, as previously described. 27 
Intramyocardial Injection of Recombinant Wnt3a or Recombinant IGFBP3
Ten microliters of recombinant Wnt3a (r-Wnt3a, 400 ng) or recombinant IGFBP3 (r-IGFBP3) proteins (1000 ng) (R&D) or vehicle (PBS) was given by intramyocardial injection into 3 sites of the left ventricular free wall of nonsurgically operated female mice (r-Wnt3a) or into the infarct/border zone area of mice immediately after MI (r-Wnt3a or r-IGFBP3).
Heart Fixation and Histology
One day after echocardiographic measurements, animals were euthanized and hearts were fixed at an end-diastolic pressure of 5 mm Hg, using a Langendorff apparatus. For details, see Methods in the Online Data Supplement.
Echocardiography
Echocardiography was performed 1 day before MI and 7 days after MI using a high-resolution, high-frequency digital imaging system (Vevo 2100, VisualSonics), as previously described. 28 For details, see Methods in the Online Data Supplement.
FACS Analysis
FACS was performed using a FACSAria (Becton Dickinson, BD) equipped with 3 lasers (488 nm, 633 nm, 355 nm). Hoechst 33342 dye was excited by an UV (355 nm) laser. Acquired data were analyzed by FACSDIVA software (BD Biosciences).
RNA Isolation and RT-PCR
RNA was extracted from CSP cells using Trizol reagent (Invitrogen) followed by RNeasy Mini Kit (Qiagen). Genomic DNA was removed using Turbo-DNA free kit (Ambion). cDNA was generated using a reverse transcription synthesis kit (Bio-Rad) and RT-PCR was performed in a MyiQ cycler (Bio-Rad). Primer sequences are available on request.
Luciferase Assays
Luciferase activity was measured using a dual luciferase kit (Promega). Cell lysates were prepared from trypsinized CSP cells and used to determine the values of Firefly and Renilla luciferases, with a 20/20 n Luminometer (Turner Biosystems).
Statistical Analysis
Statistical differences were evaluated using 1-way ANOVA analysis and Student unpaired t test, using GraphPad Prism (Version 5.03). Data are presented as meanϮSEM. A probability value Յ0.05 was considered statistically significant.
Results

Wnt3a Negatively Regulates the Growth Potential of CSP Cells Both In Vitro and In Vivo
Given the context dependency of Wnt signaling, we examined the role of Wnt signals in mediating the proliferative capacity of adult CSP cells. Under unstimulated conditions, application of recombinant SFRP2 (Soluble Frizzled-related Protein 2), a known Wnt antagonist, 29 did not affect the proliferation capacity of CSP cells in vitro, suggesting that Wnt activity in baseline CSP cells in vitro is relatively low (Online Figure I) . Treatment of CSP cells with increasing doses of Wnt3a-conditioned medium (Wnt3a-CM) resulted in a gradual activation of the canonical Wnt signaling pathway, as assessed by a T-cell factor-controlled luciferase reporter assay 30 and a respective decrease in CSP cell number, in comparison to vehicle-conditioned medium treated cells ( Figure 1A and 1B). A similar decrease in cell proliferation in response to activation of canonical Wnt signaling was also observed in CSP cells treated with recombinant Wnt3a protein (r-Wnt3a) ( Figure 1C and 1D). Likewise, BIO ((2ЈZ, 3ЈE)-6-
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Bromoindirubin-3Ј-oxime), a GSK-3 inhibitor, caused a comparable decline in CSP cell number with corresponding activation of the Wnt pathway ( Figure 1E and 1F). We further examined the antiproliferative effects of Wnt signaling on CSP cells in vivo, with direct intramyocardial injection of r-Wnt3a protein into the LV free wall of normal adult mouse hearts. Injection of r-Wnt3a substantially reduced the number of CSP cells ( Figure 1G ) in the injected area relative to vehicle, whereas the number of CSP cells remote to the injection site (atria, septum and right ventricle) remained unchanged ( Figure 1H ). (p-H3) ( Figure 2D through 2F). The altered cell cycle profile in Wnt3a-CM-treated CSP cells was further tested by direct measurement of DNA content with propidium iodide staining. As demonstrated in Figure 2G through 2I, Wnt3a-CM treatment considerably increased the amount of cells residing in G0/G1-cell cycle phases while decreasing the fraction of cells residing in S-and G2/M-cell cycle phases, in comparison to vehicle treated CSP cells.
Wnt3a Directly Alters the Cell Cycle Progression of Adult CSP Cells
To further clarify the role of Wnt signaling in the regulation of CSP cell cycle progression, we examined the expression pattern of known cell cycle regulator genes. Consistent with the impaired proliferative capacity, treatment of CSP cells with Wnt3a-CM, in comparison to vehicle, downregulated the expression of several positive cell-cycle regulators including Ki67, PCNA, and Brca2, while upregulating negative cell-cycle regulators such as Gadd45a and p16 (Cdkn2a), within 8 hours (Online Table I ). Notably, this gene expression pattern persisted throughout later time points and was accompanied by further downregulation of additional cell cycle regulators, including c-myb, Ccnf, Ccnb1, Cdk4, Mcm3, Mcm2, Cdc25a, Brca1, and Wee1 (Online Table I ). These findings suggest that canonical Wnt stimulation impairs the proliferation of adult cardiac progenitor cells potentially through modulation of cell-cycle regulators.
IGFBP3 Is Upregulated in Response to Activated Wnt Signaling in CSP Cells
Using an RT-PCR-based array to monitor several key intracellular signaling pathways, we sought to identify possible mediators for the antiproliferative action of Wnt signaling. Several genes previously identified to be associated with Wnt signaling activation (Wnt2, Tcf7, Lef1) and with cell-cycle regulation (p16) were found to be significantly upregulated in Wnt3a-CM-treated CSP cells in comparison to vehicletreated cells (Online Figure II , A, and Online Table II ). Interestingly, among those genes examined, IGFBP3 exhibited the most robust upregulation with Wnt activation, increasing more than 40-fold (Online Figure II, A) . Furthermore, IGFBP3 gene expression was upregulated by Wnt3a-CM in CSP cells in a time-dependent manner (Figure 3A). Consistent to the increased gene expression, IGFBP3 protein levels were found increased in CSP cells treated with Wnt3a-CM (Online Figure II, B ). To examine whether increased IGFBP3 was derived from de novo transcription, stabilization of IGFBP3 mRNA, or by alternative mechanisms, CSP cells were treated with actinomyosin-D, an inhibitor of de novo transcription. Actinomyosin-D abolished Wnt-mediated upregulation of IGFBP3, suggesting that the IGFBP3 induction after Wnt3a treatment was mediated predominantly by transcriptional mechanisms ( Figure 3B) . These experiments identify IGFBP3 as a potential mediator of Wnt3a signaling in adult cardiac progenitor cells.
IGFBP3 Is Sufficient to Inhibit the Proliferative Capacity of CSP Cells
To test whether the expression of IGFBP3 was sufficient to mimic the antiproliferative effects of Wnt3a, we constructed a lentiviral-vector overexpressing IGFBP3 (IGFBP3 o/e) in CSP cells (Online Figure III) . We found that the proliferative capacity of CSP cells overexpressing IGFBP3 was markedly decreased ( Figure 3C ). Consistent with this observation, overexpression of IGFBP3 resulted in a cell cycle gene expression pattern similar to that of canonical Wnt signaling, with approximately 80% of examined genes (66 genes of a total of 84 genes tested) similarly regulated in both experi- Table III ). Overall, our data suggest that IGFBP3 acts as a mediator of Wnt signaling that is sufficient to recapitulate the phenotypic response to Wnt activation in CSP cells.
IGFBP3 Is Required for Wnt3a-Mediated Antiproliferative Effects in CSP Cells
To determine whether IGFBP3 is required for the antiproliferative effects of Wnt3a, we decreased IGFBP3 protein expression in CSP cells by using lentiviral-mediated expression of a shRNA targeting IGFBP3 (sh-IGFBP3) (Online Figure IV) before Wnt activation. Scramble-infected (sh-Scramble) CSP cells treated with Wnt3a-CM exhibited decreased proliferation ( Figure 3D ), similar to uninfected cells. In contrast, silencing of IGFBP3 prevented Wnt-mediated inhibition of CSP cell proliferation ( Figure 3E ). To further investigate the role of IGFBP3 in mediating the antiproliferative effects of Wnt signaling at the gene level, we compared the expression profile of cell cycle-related genes in sh-Scramble and sh-IGFBP3 CSP cells after treatment with vehicle or Wnt3a-CM. In sh-Scramble CSP cells, 40 of the 75 (53%) expressed cell-cycle related genes were altered (upregulated or downregulated) by more than 2-fold after treatment with Wnt3a-CM ( Figure 3F and Online Table IV) , including upregulation of cell-cycle inhibitors (Cdkn2a and Cdkn1a) and downregulation of positive mediators of cellcycle progression (Ccna2, Ccnb1, E2f3, Ki67, PCNA, Mcm2, Mcm3, Mcm4, and Wee1). In sh-IGFBP3 CSP cells, only 12 of the 75 examined cell cycle regulators (16%) were altered by more than 2-fold after treatment with Wnt3a-CM ( Figure  3G and Online Table IV ). In sh-IGFBP3-infected CSP cells, Wnt signaling did not result in altered expression of negative cell-cycle regulators and even upregulated the expression of several positive regulators (Ccna2, Ccnb1, Wee1). Overall, our data suggest that silencing of IGFBP3 results in normalization of cell cycle gene expression in response to Wnt signaling activation and that IGFBP3 is necessary for the antiproliferative effects of Wnt3a activation in adult CSP cells.
Integrity of IGF-Binding Site Is Required for the Antiproliferative Effect of IGFBP3 on CSP Cells
IGFBP3 is an abundant circulating IGF-binding protein and acts as a modulator of cell survival, cell proliferation, and cell metabolism through IGF-dependent or IGF-independent mechanisms. 31 IGFBP3 is known to bind IGFs both in vitro and in vivo. 31 IGF-1 is a potent stimulant of several cell types including adult cardiac stem cells. 32 We found that IGF-1 stimulates CSP cell proliferation in vitro (Online Figure V,  A) . However, the expression of IGF-1 receptors did not change after Wnt3a treatment (Online Figure V, B and C). To determine whether IGF binding to IGFBP3 is required for the antiproliferative effect of IGFBP3, we overexpressed wildtype IGFBP3 or mutated IGFBP3 with loss of the IGF binding site (IGFBP3 mIGF ) in CSP cells. 33 Overexpression of wild-type IGFBP3 decreased cell proliferation, whereas overexpression of IGFBP3 mIGF increased cell division ( Figure  3H ), suggesting that the IGF binding site is critical for the antiproliferative function of IGFBP3 in CSP cells.
Administration of r-Wnt3a Protein After MI Diminishes the Pool of Endogenous Cardiac Progenitors
After cardiac injury, CSP cell pools are acutely depleted and later renewed, in part, through enhanced proliferation of local CSP cells. 26 Given the context and cell-type dependency of Wnt activation in response to cardiac injury, we measured Wnt-related genes in CSP cells isolated from the myocardium 1, 3, and 7 days after coronary ligation. Using a Wnt pathway focused gene array, we established that Wnt-related genes were downregulated in CSP cells early after MI and continued to decline over 7 days. Conversely, a corresponding increase in Wnt pathway inhibitor genes was detected ( Figure  4A through 4C and Online Tables V through VIII). During this early post-MI period, CSP proliferation increased, as shown by BrdU labeling (Figure 4D ). To determine whether activation of Wnt signaling may inhibit the growth capacity of CSP cells after tissue injury, r-Wnt3a was injected into the infarct and border zone of mouse hearts after MI. Injection of r-Wnt3a after MI upregulated Wnt target genes, including Ccnd1, Tcf7, Lef-1, and Wnt3a ( Figure 5A ), confirming the activation of canonical Wnt in vivo. Administration of r-Wnt3a resulted in a significant reduction in CSP cell number in the region of injection ( Figure 5B ) but did not alter CSP cell number in areas remote to the injection site (atria, right ventricle and septum) relative to vehicle treated animals ( Figure 5C ). To further determine whether the Wnt-mediated decrease in CSP pools alters myocardial regeneration after MI, we determined the formation of new cardiomyocytes by pulsing BrdU, a thymidine analog, through Alzet miniosmotic pumps for a period of 1 week. BrdU-positive cardiomyocytes were found to reside primarily in the infarct and border zone areas of the injured myocardium ( Figure 6A ) and were significantly decreased after r-Wnt3a administration compared with vehicle injected counterparts ( Figure 6B ), suggesting an impairment in new cardiomyocyte generation. Notably, the majority of BrdU-positive cardiomyocytes were smaller in size in both r-Wnt3a and vehicle-injected hearts as compared with nondividing, BrdU-negative cardiomyocytes ( Figure 6C) . A representative cluster of BrdU-positive cardiomyocytes located in the infarct/border zone area is presented in Online Figure VI . Our data show that activation of Wnt signaling pathway diminishes the endogenous repair mechanisms of the heart after MI.
Administration of Wnt or IGFBP3 Adversely Affects Post-MI Cardiac Remodeling
We further determined whether diminished CSP pools and myocardial regeneration after MI influence the development of adverse cardiac remodeling. One week after MI, heart weight/body weight ( Figure 7A ) and infarct size ( Figure 7B ) were significantly increased with r-Wnt3a injection. Moreover, injection of r-Wnt3a protein and impaired myocardial regeneration were associated with decreased intraventricular septal wall thickness, increased left ventricular chamber dimension, and impaired cardiac performance, marked by reduced ratio of fractional shortening and fractional area change, compared with vehicle-injected mice (Figure 7C through 7F). Taken together, our data suggest that activation of Wnt signaling worsens the post-MI structural and functional remodeling. Similarly, administration of r-IGFBP3 into the infarct/border zone area acutely after coronary artery occlusion resulted in a decrease in intraventricular septal thickness and an increase in left ventricular chamber dimension, as well as a corresponding reduction in LV fractional shortening and fractional area change ( Figure 8A through 8D). Collectively, these data suggest that IGFBP3 mimics the 
Discussion
Detailed knowledge of the molecular cues that regulate progenitor cell fate decisions in physiological and pathological states is of the utmost importance for achieving the overarching goal of therapeutic cardiac regeneration. Wnt signaling is a pivotal factor in the regulation of organogenesis from embryonic development to aging, as well as in various disease conditions. 9,10 Although Wnt signaling is undoubtedly established to be critical for cardiogenesis during cardiac development, 11 its role in adult cardiac progenitor cells and post-MI remodeling remains poorly understood. In this study, we define the role of canonical Wnt signaling in regulating the function of adult cardiac progenitor cells in vitro and in vivo. Furthermore, we identify a previously unknown link between canonical Wnt signaling and IGFBP3 and demonstrate an important role for IGFBP3 in mediating Wnt signaling effects in adult cardiac progenitor cells. Last, our study emphasizes the functional significance of adult cardiac progenitor cells in tissue regeneration after cardiac injury such as MI.
The antiproliferative effects of Wnt signaling on CSP cells appear to be mediated through its negative effects on the cell cycle progression. Activation of Wnt signaling leads to accumulation of CSP cells in the early nonproliferating G0/G1 cell-cycle phases, while altering substantially the expression profile of various cell cycle regulators. In contrast, prior reports suggest that Wnt signaling potentiates the expansion of embryonic and neonatal Isl-1 ϩ cardiac progenitor cells. 18 -20 The distinct response of CSP cells to Wnt signals in adult versus embryonic progenitor cells probably is due to intrinsic differences of each cell type and to the highly time and context dependent nature of Wnt signaling. 11, 17 The milieu-dependent role of Wnt signaling is also supported by recent evidence in the cancer biology field. Although Wnt signaling is associated with oncogenic transformation, it has recently been suggested that activation of Wnt signaling may decrease proliferation in melanoma cancerous cells. 34 Further, we demonstrated that IGFBP3 is transcriptionally upregulated by Wnt signaling and that it is the critical determinant of the antiproliferative effects of Wnt on CSP cells. Importantly, this phenomenon depends on a functional IGF binding site in IGFBP3. Analysis of the IGFBP3 gene promoter sequence has revealed a number of conserved transcriptional factor binding sites for factors such as REPIN1, MYOD1, and NFATC. [35] [36] [37] ChIP-chip and ChIP-seq experiments have recognized a number of other transcrip-tional factors that may bind to the promoter region of IGFBP3. 38 Recent reports suggest IGFBP5 is a potential target of Wnt-mediated transcriptional activity. 39, 40 Among the members of the IGFBP family, IGFBP3 has a high structural and functional resemblance to IGFBP5, 41, 42 raising the possibility that IGFBP3 is upregulated in CSP cells through a direct Wnt-mediated transcriptional mechanism.
The role of IGFBP proteins in the adult myocardium is largely unknown. The insulin-like growth factor axis (ratio of IGF-1 to IGFBP3) has been introduced as a predictor of clinical outcomes in heart failure patients. 43 Moreover, mice overexpressing IGFBP3 exhibited cardiac organomegaly. 44 More recently, a direct link between cardiomyogenesis, IGFBP proteins, and Wnt signaling was identified. 45 IGFBP4 increases the cardiomyogenic differentiation of P19CL6 cells and embryonic stem cells through inhibition of canonical Wnt. 45 However, IGFBP4 activates Wnt/␤-catenin transcrip- tional activity in a renal cancer cell line. 46 Thus, a contextdependent and cell type-dependent specificity may define the interaction between IGFBP proteins and Wnt.
Activation of Wnt signaling decreases resident cardiac progenitor cell renewal and negatively affects the myocardial response to infarction. SFRP1 and SFRP2, 2 welldocumented Wnt signaling inhibitors, exert a potent cardioprotective effect after ischemic myocardial injury. [47] [48] [49] [50] Similarly, depletion of ␤-catenin attenuates post-MI cardiac remodeling and improves animal survival by stimulating the resident cardiac stem cell pool. 51 Wnt signaling has been reported to be enhanced within the infarct-border zone, but Wnt activation was limited to endothelial cells, smooth muscle cells, CD31 ϩ /Sca1 ϩ cells, c-kit ϩ /CD45 ϩ cells, and fibroblasts. 52, 53 Results from the current study, however, indicate that Wnt pathway genes were decreased in CSP cells isolated from the infarcted heart, whereas Wnt inhibitors, such as SFRP2, increased. Consistent with this observation, we found that CSP cell proliferation was enhanced early after MI. Conversely, activation of Wnt signaling in CSP cells through the delivery of recombinant Wnt protein decreased the number of CSP cells. On the basis of in vitro data, it is reasonable to speculate that downregulation of Wnt signaling in CSP cells may promote the proliferation of CSP cells after cardiac injury. In addition to the effects on cardiac progenitor cells, r-Wnt3a may influence other cell types, including cardiomyocytes. Indeed, we found that r-Wnt3a leads to an increase in cardiomyocyte death (Online Figure VII, A) , but no change is observed in cell death when all cardiac cells are considered (Online Figure VII, B) . Importantly, recombinant Wnt3a results in an increase in heart weight-to-body weight ratio, although cardiomyocyte cross-sectional area remains unchanged. These results do not exclude an increase in myocyte length, which may contribute to the expansion in cavitary volume (Online Figure VIII) . Although we cannot exclude that Wnt affects other cell types, our findings point to a potential interaction between impaired progenitor cell function and negative outcome after MI. Importantly, future research is necessary to determine those cell types which underlie the in vivo effects of recombinant Wnt administration and whether targeting Wnt may be a viable therapeutic option.
In summary, our work reveals a novel role of Wnt signaling pathway in adult cardiac progenitor cells and shows that canonical Wnt ligands compromise the self-renewal properties of CSP cells in vitro and in vivo. This phenomenon, in turn, may lead to impaired cardiac recovery after ischemic injury. Furthermore, we have identified a previously unrecognized link between Wnt signaling and IGFBP3, which together regulate cardiac progenitor cell function. Canonical Wnt contributes to negative left ventricular remodeling by interfering with the endogenous myocardial regeneration. Understanding the molecular signals that modulate tissue homeostasis and repair is important for the design of novel therapeutic strategies for the failing heart. phy measurements. We also thank B. Jiang and members of Liao laboratory for discussion.
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